ID: ALA5179737

Max Phase: Preclinical

Molecular Formula: C15H15NO2

Molecular Weight: 241.29

Associated Items:

Representations

Canonical SMILES:  CC(=O)N(C)c1ccccc1Oc1ccccc1

Standard InChI:  InChI=1S/C15H15NO2/c1-12(17)16(2)14-10-6-7-11-15(14)18-13-8-4-3-5-9-13/h3-11H,1-2H3

Standard InChI Key:  SRGCVHPINYBIOC-UHFFFAOYSA-N

Associated Targets(Human)

Translocator protein 484 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 241.29Molecular Weight (Monoisotopic): 241.1103AlogP: 3.46#Rotatable Bonds: 3
Polar Surface Area: 29.54Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.58CX LogD: 2.58
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.82Np Likeness Score: -0.95

References

1. Barresi E, Robello M, Costa B, Da Pozzo E, Baglini E, Salerno S, Da Settimo F, Martini C, Taliani S..  (2021)  An update into the medicinal chemistry of translocator protein (TSPO) ligands.,  209  [PMID:33081988] [10.1016/j.ejmech.2020.112924]

Source